Abstract:Previously, we reported that the accuracy of cytological diagnosis of breast lesions could be augmented through the quantitative assessment of DNA methylation of fine-needle aspirate (FNA) washings. Herein, we aimed at the evaluation of the prognostic value of quantitative promoter methylation at three gene loci (APC, CCND2, and RASSF1A) in a large series of FNA washings from breast lesions. Methylation levels of three gene promoters were assessed by quantitative methylation-specific PCR in bisulfite-modified DNA from 211 FNA washings, comprising 178 carcinomas and 33 benign lesions, both histopathologically confirmed. Receiver operator characteristic (ROC) curve analysis was used to determine the diagnostic performance of the gene panel in distinguishing cancer from non-cancerous lesions. Relevant clinicopathologic data and time to progression and/or death from breast cancer were correlated with methylation findings. Log-rank test and Cox-regression model identified independent predictors of prognosis. APC, CCND2, and RASSF1A methylation levels differed significantly between malignant and benign lesions. ROC curve analysis confirmed the diagnostic performance of the gene panel. In univariate analysis, stage was significantly associated with overall, disease-specific and disease-free survival, whereas tumor grade was associated with disease-specific and disease-free survival. Remarkably, RASSF1A methylation was significantly and independently associated with worse disease-free survival in the final multivariate analysis. We confirmed that quantitative gene promoter methylation augments the diagnostic performance of cytopathology. Importantly, and in addition to standard clinicopathologic parameters, RASSF1A high-methylation levels are independent predictors of worse outcome in breast cancer. Thus, epigenetic biomarkers provide valuable tools for breast cancer patient management.

Rassf1a Promoter Hypermethylation Is A Strong Biomarker Of Poor Survival In Patients With Salivary Adenoid Cystic Carcinoma In A Chinese Population

Promoter Hypermethylation of Rassf1a Is A Predictor for Poor Survival of Patients with Salivary Adenoid Cystic Carcinoma In A Chinese Population

Protein Expression of RASSF1A in Salivary Adenoid Cystic Carcinoma

Methylation of Five Tumor Suppressor Genes and Their Expression in Salivary Adenoid Cystic Carcinoma Cell Lines

High Expression Of H3k9me3 Is A Strong Predictor Of Poor Survival In Patients With Salivary Adenoid Cystic Carcinoma

RASSF1A promoter methylation correlates development, progression, and poor cancer-specific survival of renal cell carcinoma: trial sequential analysis.

High RASSF1A promoter methylation levels are predictive of poor prognosis in fine-needle aspirate washings of breast cancer lesions

Promoter methylation as a common mechanism for inactivating E-cadherin in human salivary gland adenoid cystic carcinoma.

Relationship between RAS Association Domain Family Protein 1A Promoter Methylation and the Clinicopathological Characteristics in Patients with Ovarian Cancer: A Systematic Meta-Analysis.

Analysis of RASSF1A promoter hypermethylation in serum DNA of non-small cell lung cancer patients

Expression of DNA methyltransferases in salivary adenoid cystic carcinoma and its association with the CpG islands methylation of tumor suppressor genes]

Methylation of E-cadherin, p16, RASSF1A, DAPK and MGMT in salivary gland tissues

Detection of Promoter Hypermethylation in Salivary Rinses As a Biomarker for Head and Neck Squamous Cell Carcinoma Surveillance.

Mrna Expression and Promoter Hypermethylation Status of RASSF1A in Lung Carcinoma

Predictive Value of Unmethylated RASSF1A on Disease Progression in Non-Small Cell Lung Cancer Patients Receiving Pemetrexed-Based Chemotherapy

Identification Of Epigenetic Aberrant Promoter Methylation Of Rassf1a In Serum Dna And Its Clinicopathological Significance In Lung Cancer

Analysis of Clinicopathological Characteristics, MYB Rearrangement and Prognostic Factors in Salivary Adenoid Cystic Carcinoma.

Analysis of Methylation Status of RASSF1A promoter Region and Transcription Level of Downstream Genes in Non-Small Cell Lung Cancer

B-cell specific Moloney murine leukemia virus insertion site 1 contributes to invasion, metastasis, and poor prognosis in salivary adenoid cystic carcinoma

Experimental study on the relationship between RASSF1A gene promoter methylation status and laryngeal carcinoma

Detection of Rassf1a Promoter Hypermethylation in Serum from Gastric and Colorectal Adenocarcinoma Patients